Suspected adverse drug reactions of rivaroxaban reported in the United States food and drug administration adverse event reporting system database: a pharmacovigilance study
Rivaroxaban has risks of various suspected adverse reactions while providing therapeutic effects and being used widely. Our pharmacovigilance study may provide valuable hints that practitioners should closely monitor occurrences of "Gastrointestinal disorders", "Injury, poisoning, and procedural complications" and "Nervous system disorders", and other events in clinical applications. Consequently, it remains to persist in monitoring rivaroxaban, assessing the associated risks in the future.
Authors
- Fenfang Wei
- Hongqiao Li (ORCID: https://orcid.org/0000-0001-6010-8732)
- Biyu Tang
- Bei Wang (ORCID: https://orcid.org/0000-0002-8931-430X)
- Yi Zhang (ORCID: https://orcid.org/0000-0002-1600-7456)
- Limin Li (ORCID: https://orcid.org/0000-0003-0781-0594)
- Xinru Wang (ORCID: https://orcid.org/0009-0006-1545-834X)
- Wenyu Wu (ORCID: https://orcid.org/0000-0001-8579-2454)
- Xiang Hong
- Jingying Wu
- Jianru Wu
Institutions
- Shenzhen Institute of Information Technology (CN)
- Southeast University (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2024-09-06
- DOI
- https://doi.org/10.3389/fphar.2024.1399172
- Citations
- 7
- Primary Topic
- Pharmacovigilance and Adverse Drug Reactions
- Type
- article
- Field-Weighted Citation Impact
- 2.45
Funders
- National Natural Science Foundation of China
- Government of Jiangsu Province
- Natural Science Foundation of Jiangsu Province
- Basic and Applied Basic Research Foundation of Guangdong Province